Abstract
Nomifensine, an antidepressant used for eight years in Britain, was particularly popular in the north west of England. Haemolytic anaemia was recognised as a rare side effect, but in 1984 a cluster of six cases was referred to the North West Regional Transfusion Centre, reflecting an incidence of 0.006%. These were collected within 18 months and showed variable serological features, indicating that antibodies associated with nomifensine treatment are neither rare nor of one particular type. The accumulation of this and similar data contributed to its withdrawal from the British market in January, 1986.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Habibi B., Cartron J. P., Bretagne M., Rouger P., Salmon C. Anti-nomifensine antibody causing immune hemolytic anemia and renal failure. Vox Sang. 1981 Feb;40(2):79–84. doi: 10.1111/j.1423-0410.1981.tb00673.x. [DOI] [PubMed] [Google Scholar]
- Lylloff K., Jersild C., Bacher T., Slot O. Massive intravascular haemolysis during treatment of nomifensine. Lancet. 1982 Jul 3;2(8288):41–41. doi: 10.1016/s0140-6736(82)91171-0. [DOI] [PubMed] [Google Scholar]
- Prescott L. F., Illingworth R. N., Critchley J. A., Frazer I., Stirling M. L. Acute haemolysis and renal failure after nomifensine overdosage. Br Med J. 1980 Nov 22;281(6252):1392–1393. doi: 10.1136/bmj.281.6252.1392-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salama A., Mueller-Eckhardt C. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med. 1985 Aug 22;313(8):469–474. doi: 10.1056/NEJM198508223130803. [DOI] [PubMed] [Google Scholar]
- Sokol R. J., Hewitt S., Booker D. J., Stamps R., Taylor M., Stewart R. M. Fatal immune haemolysis associated with nomifensine. Br Med J (Clin Res Ed) 1985 Aug 3;291(6491):311–312. doi: 10.1136/bmj.291.6491.311-a. [DOI] [PMC free article] [PubMed] [Google Scholar]